Biomedicines (Dec 2021)

Combination Biomarker of Immune Checkpoints Predict Prognosis of Urothelial Carcinoma

  • Chung-Ying Tsai,
  • Hsiang-Cheng Chi,
  • Ren-Chin Wu,
  • Cheng-Hao Weng,
  • Tzong-Shyuan Tai,
  • Chan-Yu Lin,
  • Tai-Di Chen,
  • Ya-Hui Wang,
  • Li-Fang Chou,
  • Shen-Hsing Hsu,
  • Po-Hung Lin,
  • See-Tong Pang,
  • Huang-Yu Yang

DOI
https://doi.org/10.3390/biomedicines10010008
Journal volume & issue
Vol. 10, no. 1
p. 8

Abstract

Read online

In contrast to Western counties, the incidence of urothelial carcinoma (UC) remains mar-edly elevated in Taiwan. Regulatory T cells (Tregs) play a crucial role in limiting immune responses within the tumor microenvironment. To elucidate the relationship between immune checkpoints in the tumor immune microenvironment and UC progression, we utilize the Gene Expression Omnibus (GEO) to analyze a microarray obtained from 308 patients with UC. We observed that the expression level of CD276 or TIM-3 was positively correlated with late-stage UC and poor prognosis. Patients with simultaneously high CD276 and TIM-3 expression in tumors have significantly reduced both univariate and multivariate survival, indicating that mRNA levels of these immune checkpoints could be independent prognostic biomarkers for UC overall survival and recurrence. Our cohort study showed rare CD8+ cytotoxic T-cells and Tregs infiltration during early-stage UC-known as cold tumors. Approximately 30% of late-stage tumors exhibited highly infiltrated cytotoxic T cells with high PD-1 and FOXP3 expression, which implied that cytotoxic T cells were inhibited in the advanced UC microenvironment. Collectively, our findings provide a better prognosis prediction by combined immune checkpoint biomarkers and a basis for early-stage UC standard treatment to convert cold tumors into hot tumors, followed by immune checkpoint therapy.

Keywords